Recently, the number of applications of composite materials using foam cores is expanding to reduce weight and increase the ...

Asahi Kasei is a diversified industrial group – with fingers in a lot of pies, including chemicals, construction, and energy – but in recent years has made expansion in the pharma and medical ...

In this interview, NewsMedical speaks with Esther Kieserman and Arvonn Tully from Yokogawa Life Science about how confocal-based high-content imaging is advancing core facility research and ...

Asahi Kasei Corp is a Japan-based company mainly engaged in the ... The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary ...

TOKYO & NEW YORK & DÜSSELDORF, October 22, 2024--Asahi Kasei Medical has launched the Planova™ FG1, a virus removal filter featuring higher flux for the manufacture of biotherapeutics.

TOKYO & NEW YORK & DÜSSELDORF, October 22, 2024--Asahi Kasei Medical has launched the Planova™ FG1, a virus removal filter featuring higher flux for the manufacture of biotherapeutics.

The new process development and pilot plant facility on Fremont Boulevard represents a $14 million investment by Bionova and its parent company, Tokyo-based Asaha Kasei Medical. The company also ...

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to ...

Swiss drug developer Basilea Pharmaceutica reported that the sales of the antifungal Cresemba (isavuconazole) in Japan exceeded the threshold triggering the first sales milestone payment from its ...

TOKYO & NEW YORK & DÜSSELDORF, October 22, 2024--Asahi Kasei Medical has launched the Planova™ FG1, a virus removal filter featuring higher flux for the manufacture of biotherapeutics. DÜSSELDORF, ...